AviadoBio
- Headquarters
- London
- Founded
- 2021
- Business Model
- B2B
- Website
- aviadobio.com
- Total Funding
- $168.0M
About
AviadoBio is a biotechnology company developing transformative gene therapies for neurodegenerative disorders using a novel neuroanatomy-led approach to drug delivery.
Funding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account